{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:27:16Z","timestamp":1758040036953,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ahj.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T07:26:29Z","timestamp":1615274789000},"page":"136-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures"],"prefix":"10.1016","volume":"234","author":[{"given":"Anne-C\u00e9line","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Hausleiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2020.10.056","article-title":"Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair","volume":"232","author":"Nathan","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.01.004_bib0002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","article-title":"One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry","volume":"37","author":"Puls","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.01.004_bib0003","doi-asserted-by":"crossref","first-page":"824","DOI":"10.21037\/acs.2018.10.14","article-title":"Transcatheter mitral repair: MitraClip technique","volume":"7","author":"Ramlawi","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2021.01.004_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.01.004_bib0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCULATIONAHA.117.033326","article-title":"Management of intraprocedural anticoagulation in patients on non-vitamin K antagonist oral anticoagulants undergoing catheter ablation for atrial fibrillation","volume":"138","author":"Martin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.01.004_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020350","article-title":"Activated clotting time monitoring during atrial fibrillation catheter ablation: does the anticoagulant matter?","volume":"9","author":"Martin","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ahj.2021.01.004_bib0007","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/eurheartj\/ehx403","article-title":"Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study","volume":"38","author":"Godier","year":"2017","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:06:37Z","timestamp":1757570797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":7,"alternative-id":["S0002870321000089"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.01.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}